3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Breast Neoplasms
3
Diabetes Mellitus
2
Vomiting
1
Sarcoma, Synovial
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Prostatic Neoplasms
1
Premature Birth
1
Pre-Eclampsia
1
Polycystic Ovary Syndrome
1
Parathyroid Neoplasms
1
Neoplasms
1
Medulloblastoma
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Hairy Cell
1
Leukemia, B-Cell
1
Leiomyosarcoma
1
Hyperparathyroidism, Primary
1
Hot Flashes
1
HER2 IHC3+ Advanced Colorectal Cancer
1
Erectile Dysfunction
1
Cognitive Dysfunction
1
Carcinoma, Renal Cell
1
Interventions
Vincristine
4
Platinum
4
Cyclophosphamide
4
Cisplatin
4
1,2-diaminocyclohexaneplatinum II citrate
4
Radiotherapy
3
Radiation
3
Granulocyte Colony-Stimulating Factor
3
Filgrastim
3
sodium thiosulfate
2
Specimen Handling
2
Metformin
2
Magnetic Resonance Spectroscopy
2
Lomustine
2
Carboplatin
2
merphos
1
Thiotepa
1
Tablets
1
Stem Cell Transplantation
1
Spinal Puncture
1
Restraint, Physical
1
Methotrexate
1
Leucovorin
1
Isotretinoin
1
Hearing
1
Fentanyl
1
Evoked Potentials, Auditory, Brain Stem
1
Etoposide
1
Donepezil
1
Cyproheptadine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Medulloblastoma
×
Tablets
×
Clear all
NCT05230758
2026-05-01
Met Med Can
The Hospital for Sick Children
Phase 3
Recruiting
140 enrolled